Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
-
- 佐野, 絵美
- Center for iPS Cell Research and Application (CiRA), Kyoto University
-
- 出口, 清香
- Center for iPS Cell Research and Application (CiRA), Kyoto University
-
- 坂本, 綾香
- Center for iPS Cell Research and Application (CiRA), Kyoto University
-
- 三村, 菜摘
- Center for iPS Cell Research and Application (CiRA), Kyoto University
-
- 平林, 愛
- CREST, Japan Science and Technology Agency (JST); Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University
-
- 村本, 裕紀子
- CREST, Japan Science and Technology Agency (JST); Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University
-
- 野田, 岳志
- CREST, Japan Science and Technology Agency (JST); Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University
-
- 山本, 拓也
- Center for iPS Cell Research and Application (CiRA), Kyoto University; Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University; Medical-risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Project (AIP); AMED-CREST, Japan Agency for Medical Research and Development (AMED)
-
- 高山, 和雄
- Center for iPS Cell Research and Application (CiRA), Kyoto University
説明
Genetic differences are a primary reason for differences in the susceptibility and severity of COVID-19. As induced pluripotent stem (iPS) cells maintain the genetic information of the donor, they can be used to model individual differences in SARS-CoV-2 infection in vitro. We found that human iPS cells expressing the SARS-CoV-2 receptor angiotensin-converting enzyme 2 (ACE2) (ACE2-iPS cells) can be infected w SARS-CoV-2. In infected ACE2-iPS cells, the expression of SARS-CoV-2 nucleocapsid protein, budding of viral particles, and production of progeny virus, double membrane spherules, and double-membrane vesicles were confirmed. We performed SARS-CoV-2 infection experiments on ACE2-iPS/ embryonic stem (ES) cells from eight individuals. Male iPS/ES cells were more capable of producing the virus compared with female iPS/ES cells. These findings suggest that ACE2-iPS cells can not only reproduce individual differences in SARS-CoV-2 infection in vitro but also are a useful resource to clarify the causes of individual differences in COVID-19 due to genetic differences.
収録刊行物
-
- iScience
-
iScience 24 (5), 102428-, 2021-05
Elsevier BV
関連論文
もっと見る- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050850932905018368
-
- NII論文ID
- 120007032353
-
- HANDLE
- 2433/262724
-
- ISSN
- 25890042
-
- PubMed
- 33880436
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- IRDB
- Crossref
- CiNii Articles
- KAKEN
- OpenAIRE